Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.
暂无分享,去创建一个
M. Hennig | M. Del Poeta | A. Merrill | J. Allegood | C. Luberto | Mirko Hennig | Chiara Luberto | Alfred H Merrill | Maurizio Del Poeta | Jeremy C Allegood | Philipp Rittershaus | T. Kechichian | Philipp C Rittershaus | Talar B Kechichian
[1] M. Ohnishi,et al. Presence of glucosylceramide in yeast and its relation to alkali tolerance of yeast , 2006, Applied Microbiology and Biotechnology.
[2] C. Steegborn,et al. Cryptococcus neoformans Senses CO2 through the Carbonic Anhydrase Can2 and the Adenylyl Cyclase Cac1 , 2006, Eukaryotic Cell.
[3] M. Del Poeta,et al. Role of Sphingolipids in Microbial Pathogenesis , 2006, Infection and Immunity.
[4] M. Tuite,et al. Fungal Adenylyl Cyclase Integrates CO2 Sensing with cAMP Signaling and Virulence , 2005, Current Biology.
[5] J. Heitman,et al. Carbonic Anhydrase and CO2 Sensing during Cryptococcus neoformans Growth, Differentiation, and Virulence , 2005, Current Biology.
[6] W. Leuchtenberger,et al. Biotechnological production of amino acids and derivatives: current status and prospects , 2005, Applied Microbiology and Biotechnology.
[7] K. Hanada. Sphingolipids in infectious diseases. , 2005, Japanese journal of infectious diseases.
[8] A. Merrill,et al. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. , 2005, Methods.
[9] R. Wait,et al. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages. , 2004, Microbes and infection.
[10] B. Thomma,et al. Defensins from Insects and Plants Interact with Fungal Glucosylceramides* , 2004, Journal of Biological Chemistry.
[11] E. Heinz,et al. Recently discovered functions of glucosylceramides in plants and fungi , 2003, Cellular and Molecular Life Sciences CMLS.
[12] Fabrice Chrétien,et al. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. , 2002, The Journal of infectious diseases.
[13] J. Shayman,et al. Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP‐Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth , 2002, FEBS letters.
[14] R. Wait,et al. Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation. , 2002, Glycobiology.
[15] A. Casadevall,et al. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Casadevall,et al. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] E. Heinz,et al. Glucosylceramide Synthases, a Gene Family Responsible for the Biosynthesis of Glucosphingolipids in Animals, Plants, and Fungi* , 2001, The Journal of Biological Chemistry.
[18] S. Levitz. Cryptococcus neoformans: intracellular or extracellular? , 2001, Trends in microbiology.
[19] R. Pagano,et al. Identification of Active Site Residues in Glucosylceramide Synthase , 2001, The Journal of Biological Chemistry.
[20] A. Casadevall,et al. Intracellular parasitism of macrophages by Cryptococcus neoformans. , 2001, Trends in microbiology.
[21] E. Suzuki,et al. Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum: expression of 2-hydroxy fatty N-acyl (E)-Delta(3)-unsaturation correlates with the yeast-mycelium phase transition. , 2001, Glycobiology.
[22] A. Casadevall,et al. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. , 2001, Genes & development.
[23] S. Levery,et al. Structure elucidation of sphingolipids from the mycopathogen Sporothrix schenckii: identification of novel glycosylinositol phosphorylceramides with core manalpha1-->6Ins linkage. , 2001, Biochemical and biophysical research communications.
[24] E. Suzuki,et al. Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants. , 2001, Glycobiology.
[25] W. de Souza,et al. Human Antibodies against a Purified Glucosylceramide from Cryptococcus neoformans Inhibit Cell Budding and Fungal Growth , 2000, Infection and Immunity.
[26] E. Heinz,et al. Characterization of UDP-glucose:ceramide glucosyltransferases from different organisms. , 2000, Biochemical Society transactions.
[27] A. Casadevall,et al. Cryptococcus neoformans Is a Facultative Intracellular Pathogen in Murine Pulmonary Infection , 2000, Infection and Immunity.
[28] S. Levery,et al. Dimorphic expression of cerebrosides in the mycopathogen Sporothrix schenckii. , 2000, Journal of lipid research.
[29] A. Merrill,et al. Structure determination of soybean and wheat glucosylceramides by tandem mass spectrometry. , 2000, Journal of mass spectrometry : JMS.
[30] E. Suzuki,et al. Characterization of sphingolipids from mycopathogens: factors correlating with expression of 2-hydroxy fatty acyl (E)-Delta 3-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus. , 1999, Biochemistry.
[31] T. Harrison,et al. Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages , 1999, Infection and Immunity.
[32] E. Suzuki,et al. Isolation and possible composition of glucosylceramides from Paracoccidioides brasiliensis. , 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[33] Y. Hirabayashi,et al. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Casadevall,et al. Cryptococcus neoformans survive and replicate in human microglia. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[35] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[36] E. Suzuki,et al. Glycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-containing glycolipid reactive with sera of patients with paracoccidioidomycosis. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[37] B. Frommer,et al. The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. , 1995, The Journal of antibiotics.
[38] H. Egge,et al. Structural determination of N-2'-hydroxyoctadecenoyl-1-O-beta-D-glucopyranosyl-9-methyl-4, 8-sphingadienine from species of Aspergillus. , 1994, Chemistry and physics of lipids.
[39] A. J. Shaka,et al. Iterative schemes for bilinear operators; application to spin decoupling , 1988 .
[40] Y. Banno,et al. Cerebroside of the dimorphic human pathogen, Candida albicans. , 1987, Chemistry and physics of lipids.
[41] J. Perfect,et al. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. , 1985, The Journal of clinical investigation.
[42] S. Klotz,et al. The critical role of CO2 in the morphogenesis of Coccidioides immitis in cell-free subcutaneous chambers. , 1984, The Journal of infectious diseases.
[43] J. Sanders,et al. The suppression of Bloch-Siegert shifts and subtraction artifacts in double-resonance difference spectroscopy , 1982 .
[44] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.